Orthofix Medical Inc.
NMS: OFIXLive Quote
📈 ZcoreAI Score
Our AI model analyzes Orthofix Medical Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get OFIX Z-Score →About Orthofix Medical Inc.
Healthcare
Medical Devices
Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation implant products for use throughout the spinal column; and offers bone graft substitutes, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers in various forms with supporting graft delivery solutions to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and 7D FLASH Navigation System, a navigation platform for spinal and cranial procedures. The Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market, including deformity correction, limb lengthening, complex fracture management, and limb preservation. This segment also designs, develops, and markets external and internal fixation limb reconstruction products that are coupled with enabling digital technologies to support the entire patient care continuum. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, healthcare providers, ambulatory surgery centers, and out-patient hospitals. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
📊 Fundamental Analysis
Orthofix Medical Inc. demonstrates a profit margin of -11.2%, which is below the sector average, suggesting competitive pressure.
The company recently reported 2.0% revenue growth, which is modest compared to its industry peers.
Return on Equity (ROE) is -19.3%, which indicates that capital utilization is currently under pressure.
At a current price of $12.38, OFIX currently sits at the 32nd percentile of its 52-week range (Range: $10.24 - $16.99).
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Debt/Equity
Excellent
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$496.99M
Trailing P/E
--
Forward P/E
14.48
Beta (5Y)
0.82
52W High
$16.99
52W Low
$10.24
Avg Volume
267K
Day High
Day Low